Literature DB >> 1973491

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease.

E Matsuura, Y Igarashi, M Fujimoto, K Ichikawa, T Koike.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1973491     DOI： 10.1016/0140-6736(90)91697-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  83 in total

Review 1.  Diagnosis and management of inherited and acquired thrombophilias.

Authors:  F A Spencer; R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Cardiolipin is a normal component of human plasma lipoproteins.

Authors:  H Deguchi; J A Fernandez; T M Hackeng; C L Banka; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

3.  Optimising testing for phospholipid antibodies.

Authors:  M Helbert; S Bodger; J Cavenagh; D D'Cruz; J M Thomas; P MacCallum
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

Review 4.  Antiphospholipid antibodies and infections.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 5.  Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.

Authors:  R Cervera; R A Asherson; M L Acevedo; J A Gómez-Puerta; G Espinosa; G De La Red; V Gil; M Ramos-Casals; M García-Carrasco; M Ingelmo; J Font
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 6.  Antiphospholipid syndrome: laboratory testing and diagnostic strategies.

Authors:  Thomas L Ortel
Journal:  Am J Hematol       Date:  2012-03-31       Impact factor: 10.047

7.  Anticardiolipin antibodies in leptospirosis.

Authors:  F P Rugman; G Pinn; M F Palmer; M Waite; C R Hay
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

8.  Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.

Authors:  Yao-Hsu Yang; Kwan-Ki Hwang; John FitzGerald; Jennifer M Grossman; Mihaela Taylor; Bevra H Hahn; Pojen P Chen
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

9.  Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome.

Authors:  J Ordi-Ros; J Villarreal; F Monegal; S Sauleda; I Esteban; M Vilardell
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

10.  Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.

Authors:  N Di Simone; E Raschi; C Testoni; R Castellani; M D'Asta; T Shi; S A Krilis; A Caruso; P L Meroni
Journal:  Ann Rheum Dis       Date:  2004-07-15       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.